Dr. Patricia M. O'Hare, MD

Dr. O'Hare practices at Brune Dermatology in Corvallis, Oregon.

Dr. O'Hare's NPI, 1821030693, was assigned on June 13, 2006. Dr. O'Hare graduated from Oregon Health Sciences University School of Medicine in 1993. Dr. O'Hare holds Oregon license MD19092.

Dr. O'Hare's primary practice is Brune Dermatology, at 1740 NW 9th St, Corvallis, OR 97330 in Benton County. The practice phone is (541) 230-1350.

Dr. O'Hare's primary practice is Brune Dermatology in Corvallis, Oregon. The medical group on file is Brune Dermatology, LLC. Dmand AI also links Dr. O'Hare to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Hare practices. Vendor and product names are available with a free account.

Dermatology is Dr. O'Hare's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. O'Hare is licensed in Oregon.

CMS data shows 2,454 Medicare services from Dr. O'Hare across 13 procedure codes in 2024, for 895 Medicare patients. Medicare paid $90,788 for them. Every service was in an office.

CMS counts 895 Medicare patients who saw Dr. O'Hare in 2024. The largest group is 65 to 74, with 428 patients. 61% of them have high cholesterol, and 56% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. O'Hare's median patient age at 73, with 64% women.

In 2024, Dr. O'Hare wrote 742 Medicare Part D claims for 304 patients. 80% of them were for generic drugs. CMS names the drug for 569 of them, across 20 drugs with 11 or more claims each, at $482,662 in total drug cost. In 2023, CMS named 324 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. O'Hare for performance year 2024, reported as part of a group. Dr. O'Hare accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 937 procedures of removal of skin lesions by Dr. O'Hare, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. O'Hare, published from 2011 to 2024. 2017 was the busiest year, with 2. The most frequent topics are Glioma, Brain Neoplasms and Protein Kinase Inhibitors. Dr. O'Hare has published most often in Neuroimage Clin. Dr. O'Hare's most frequent co-authors are David Michael Ashley, MBBS, PhD, Tabitha Cooney, MD and Jason Fangusaro, MD.

CMS Open Payments shows 29 general payments to Dr. O'Hare from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Janssen Pharmaceuticals, Inc paid the most, $4,530.

Dr. O'Hare graduated from Oregon Health Sciences University School of Medicine in 1993.